Literature DB >> 35774925

Use of muscular flaps for the treatment of knee prosthetic joint infection: A systematic review.

Giuseppe Rovere1, Amarildo Smakaj1, Sara Calori1, Marco Barbaliscia1, Antonio Ziranu1, Elisabetta Pataia1, Giulio Maccauro1, Domenico De Mauro1, Francesco Liuzza1.   

Abstract

Deep periprosthetic infection after total knee arthroplasty is a serious and challenging complication for the orthopedic surgeon. Muscular flaps may represent a valid treatment option for the treatment of this condition. We present a systematic literature review about the use of muscular flaps for the treatment of knee prosthetic joint infection. The review is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 70 articles, out of 589 titles, were considered eligible for the full-text analysis. Finally, 27 studies that met inclusion criteria were included in this review. Overall, 345 patients (139 males, 206 females) suffering from TKA infection treated with muscular flaps were collected. The mean age was 57.3 years. Mean follow-up, reported in all studies, was 30.1 months. The results presented by the different authors, highlight the effectiveness of muscular flaps for the treatment of periprosthetic infection, in terms of function, limb salvage, prevention of recurrences, cost-effectiveness, and quality of life postoperatively. Muscle flaps provide an excellent management option for patients with persistent infection after total knee arthroplasty.

Entities:  

Keywords:  Arthroplasty; joint infection; knee prosthesis; knee replacement; muscular flaps

Year:  2022        PMID: 35774925      PMCID: PMC9239382          DOI: 10.52965/001c.33943

Source DB:  PubMed          Journal:  Orthop Rev (Pavia)        ISSN: 2035-8164


  47 in total

Review 1.  Hip megaprosthesis in oncological surgery: open questions.

Authors:  M S Oliva; G Masci; R Vitiello; V De Santis; F Liuzza; A Grasso; F Minutillo; G Maccauro; G Cazzato
Journal:  J Biol Regul Homeost Agents       Date:  2019 Mar-Apr       Impact factor: 1.711

2.  Salvage of jeopardized total-knee prosthesis: the role of the gastrocnemius muscle flap.

Authors:  B Greenberg; D LaRossa; P A Lotke; J B Murphy; R B Noone
Journal:  Plast Reconstr Surg       Date:  1989-01       Impact factor: 4.730

3.  Infected total knee arthroplasty. Two-stage reimplantation with a gastrocnemius rotational flap.

Authors:  E J McPherson; M J Patzakis; J E Gross; P D Holtom; M Song; L D Dorr
Journal:  Clin Orthop Relat Res       Date:  1997-08       Impact factor: 4.176

4.  Single use instruments for total knee arthroplasty.

Authors:  Michele Romeo; Giuseppe Rovere; Leonardo Stramazzo; Francesco Liuzza; Luigi Meccariello; Giulio Maccauro; Lawrence Camarda
Journal:  Med Glas (Zenica)       Date:  2021-02-01

5.  Management of exposed total knee prostheses with microvascular tissue transfer.

Authors:  Curtis L Cetrulo; Travis Shiba; Michael T Friel; Brian Davis; Rudolph F Buntic; Gregory M Buncke; Darrell Brooks
Journal:  Microsurgery       Date:  2008       Impact factor: 2.425

6.  Silver-Coated Hip Megaprosthesis in Oncological Limb Savage Surgery.

Authors:  F Donati; G Di Giacomo; S D'Adamio; A Ziranu; S Careri; Ma Rosa; G Maccauro
Journal:  Biomed Res Int       Date:  2016-08-23       Impact factor: 3.411

7.  What's the resolutive surgery for pseudo-ainhum in Vohwinkel syndrome? A case report and review of the literature.

Authors:  Giuseppe Rovere; Leonardo Stramazzo; Alessio Cioffi; Nicolò Galvano; Davide Pavan; Giuseppe Restuccia; Antonio D'Arienzo; Rodolfo Capanna; Giulio Maccauro; Michele D'Arienzo; Lawrence Camarda
Journal:  Orthop Rev (Pavia)       Date:  2021-02-01

8.  COVID-19 pandemic: management of patients affected by SARS-CoV-2 in Rome COVID Hospital 2 Trauma Centre and safety of our surgical team.

Authors:  Domenico De Mauro; Giuseppe Rovere; Alessandro Smimmo; Cesare Meschini; Fabrizio Mocini; Giulio Maccauro; Francesco Falez; Francesco Liuzza; Antonio Ziranu
Journal:  Int Orthop       Date:  2020-07-15       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.